Clinical trials, between science and financial and academic interests
Pierre Chirac
The Crash team was delighted to welcome Pierre Chirac, pharmacist and editor of the magazine Prescrire, for a conference on his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation. This meetting was prepared and moderated by Rony Brauman.
On May 22, the Lancet published a peer-reviewed article based on an analysis of 96,000 Covid patient files, which concluded that hydroxychloroquine was ineffective. A few days later, researchers published a letter questioning the methodology and data used by the Surgisphere company to develop this conclusion, and on June 4, the Lancet withdrew the article from publication. This was the beginning of what some people call "Lancetgate", or the "Surgisphere Scandal".
Beyond the frenzy of scientific publications triggered by the Covid-19 outbreak (47,000 in three months!), this event highlighted the questionable reliability of clinical trials. In September 2009, the scientific journal PloS Medicine argued that most trials of new drugs, including those supposedly authored by academic physicians, are subject to frequent manipulation. The title of their editorial clearly indicates scorn: Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger, and the piece specifically outlines the influence and power of drug manufacturers in the clinical research process. Yet the poor quality studies published by French hospital doctors on hydroxychloroquine, even with no link to pharmaceutical companies, show that the problem goes far beyond that of trials financed by 'Big Pharma'.
To cite this content :
Pierre Chirac, “Clinical trials, between science and financial and academic interests”, 8 octobre 2020, URL : https://msf-crash.org/en/conferences-debates/clinical-trials-between-science-and-financial-and-academic-interests
If you would like to comment on this article, you can find us on social media or contact us here:
Contribute
Daro Sulakauri
Opinion
No credit for Drs Knock
12/01/2009Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.
Giorgos Moutafis
Analysis
Postface à l’ouvrage "Médiator 150mg"
06/30/2010Ce texte est une postface au livre du Dr Irène Frachon Médiator, 150mg dont le sous-titre « Combien de morts ?», a été retiré à la suite d'une plainte du laboratoire Servier, producteur du médicaments incriminé. Rony Brauman y aborde la question du poids croissant des compagnies pharmaceutiques dans les décisions de santé publique.
Aurelie Baumel
Interview
Santé mondiale. L’évolution vers la privatisation
12/01/2014Pour Rony Brauman, la question de la santé globale se caractérise d'abord et avant tout par la circulation des agents infectieux et toxiques qui relève d'une action mondiale.
Past events
Maëlle Lefeuvre/MSF
Conference
Waging war for peace
05/05/2026 - 06:30 PM 08:30 PMOn Tuesday, May 5th, 2026, at the headquarters of MSF (14-34 avenue Jean Jaurès, 75019), the CRASH team was delighted to welcome Sylvain Venayre, professor of contemporary history and writer, for a conference on the distant wars of the 19th century and the debates they continue to spark today. This exchange was prepared and moderated by Rony Brauman.
Maëlle Lefeuvre/MSF
Conference
Why defend multilateralism?
03/24/2026 - 06:30 PM 08:30 PMOn Tuesday, March 24th, 2026, we had the pleasure of welcoming Monique Chemillier-Gendreau, Professor Emerita of Public Law and Political Science, for a conference devoted to multilateralism in the current geopolitical context. This event was prepared and presented by Rony Brauman.
Mathilde Chong/MSF
Conference
Gaza, Ukraine. How AI and drones are transforming the violence of war
10/14/2025 - 06:30 PM 08:30 PMOn Tuesday, October 14, 2025, the CRASH team was pleased to welcome Laure de Roucy-Rochegonde and Amélie Ferey for a conference on the transformation of war violence in the age of artificial intelligence (AI) and drones. The discussion was prepared and moderated by Fabrice Weissman.
Conference
Human shields. When humanitarian law turns against war victims
06/12/2025 - 06:30 PM 08:30 PMOn Thursday June 12, 2025, the Crash team was delighted to welcome Neve Gordon and Nicola Perugini, for a conference entitled " Human shields. When humanitarian law turns against war victims". This meeting was prepared and moderated by Fabrice Weissman and Hakim Chkam.
Conference
Russian influence strategies in Africa
04/03/2025 - 06:30 PM 08:30 PMOn Thursday April 3, the Crash team was delighted to welcome Maxime Audinet, researcher at IRSEM, for a conference on Russia's new trajectories in Africa. This meeting, prepared with Michaël Neuman (Crash), was moderated by Guillaume Baret (Operations Department).
Conference
Port-au-Prince, Haiti: living and working in chaos?
02/06/2025 - 06:30 PM 08:30 PMOn Thursday February 6, the Crash team was delighted to welcome Romain Le Cour Grandmaison, Arnaud Dandoy, Pascale Solages and Sarah Chateau (MSF) for a conference entitled “Port-au-Prince, Haiti: living and working in chaos?”. This meeting was prepared and moderated by Judith Soussan.